Pier 88 Investment Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $426K | Sell |
|
|||||
|
2025
Q2 | $536K | Sell |
|
|||||
|
2025
Q1 | $810K | Buy |
|
|||||
|
2024
Q4 | $593K | Sell |
|
|||||
|
2024
Q3 | $1.25M | Sell |
|
|||||
|
2024
Q2 | $1.07M | Buy |
|
|||||
|
2024
Q1 | $713K | Sell |
|
|||||
|
2023
Q4 | $985K | Buy |
|
|||||
|
2023
Q3 | $416K | Sell |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $872K | Hold |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $946K | Buy |
|
|||||
|
2022
Q2 | $928K | Hold |
|
|||||
|
2022
Q1 | $1.13M | Hold |
|
|||||
|
2021
Q4 | $1.31M | Buy |
|
|||||
|
2021
Q3 | $1.09M | Buy |
|
|||||
|
2021
Q2 | $673K | Buy |
|
|||||
|
2021
Q1 | $656K | Buy |
|
|||||
|
2020
Q4 | $459K | Sell |
|
|||||
|
2020
Q3 | $941K | Sell |
|
|||||
|
2020
Q2 | $1.29M | Buy |
|
|||||
|
2020
Q1 | $652K | Hold |
|
|||||
|
2019
Q4 | $626K | Buy |
|
|||||
|
2019
Q3 | $553K | Buy |
|
|||||
|
2019
Q2 | $658K | Hold |
|
|||||
|
2019
Q1 | $719K | Buy |
|
|||||
|
2018
Q4 | $318K | Buy |
|
|||||
|
2018
Q3 | $538K | Buy |
|
|||||
|
2018
Q2 | $446K | Buy |
|